Skip to main content
. 2016 Oct 3;57(3):312–320. doi: 10.1002/jcph.819

Figure 7.

Figure 7

Change from baseline (CFB) in serum biomarkers of oxidative stress (isofuran, F2‐isoprostanes, and malondialdehyde [MDA]) and inflammation (interleukin‐6 [IL‐6]) at end of infusion for ferric pyrophosphate citrate (FPC) iron and placebo.